Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, d-dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarction ≤45 years of age

American Journal of Cardiology

Volumn 94, Issue 11, 2004, Pages 1410-1413

  Saigo, Masahiko ^a,b,d   Waters, David D ^a   Abe, Satoshi ^b   Biro, Sadatoshi ^b   Minagoe, Shinichi ^b   Maruyama, Ikuro ^c   Tei, Chuwa ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Respiratory and Metabolic Medicine   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d Metab Med Grad Sch Med K   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; D DIMER; FIBRIN; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBOPLASTIN;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; FIBRIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS;

EID: 9344259116     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.07.144     Document Type: Article

References (20)

1. F.H. Zimmerman, A. Cameron, L. Fisher, G. Ng Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry) J Am Coll Cardiol 26 1995 654 661
2. P. Bavenholm, U. de Fair, C. Landau, S. Efendic, J. Nilsson, B. Wiman, A. Hamsten Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function Eur Heart J 19 1998 402 410
3. M. Saigo, S. Abe, M. Ogawa, T. Yamashita, S. Biro, S. Minagoe, I. Maruyama, C. Tei Imbalance of plasminogen activator inhibitor-I/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction Thromb Haemost 86 2001 1197 1203
4. C.E. Dempfle, S. Zips, H. Ergül, D.L. Heene the FACT study group The Fibrin Assay Comparison Trial (FACT): correlation of soluble fibrin assays with d-dimer Thromb Haemost 86 2001 1204 1209
5. A. Hamano, S. Tanaka, Y. Takeda, M. Umeda, Y. Sakata A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma Clin Chem Acta 318 2002 25 32
6. C.E. Dempfle, J.J. Kaden, K. Hasse, M. Borggrefe Course of indicators of thrombin activity in the early phase of acute myocardial infarction: effect of fibrinolytic therapy and acute percutaneous coronary angioplasty Thromb Haemost 90 2003 147 154
7. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
8. P.M. Ridker, J.E. Buring, J. Shin, M. Matias, C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
9. J. Danesh, R. Collins, P. Appleby, R. Peto Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analysis of prospective study JAMA 279 1998 1477 1482
10. G.D.O. Lowe, J.W. Yarnell, A. Rumley, D. Bainton, D.M. Sweetnam C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell Study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 21 2001 603 610
11. S. Yamada, T. Gotoh, Y. Nakashima, K. Kayaba, S. Ishikawa, N. Nago, Y. Nakamura, Y. Itoh, E. Kajii Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population Am J Epidemiol 153 2001 1183 1190
12. L.A. Sechi, L. Zingaro, C. Catena, D. Casaccio, S. De Marchi Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension Hypertension 36 2000 978 985
13. J.A. Cooper, G.J. Miller, K.A. Bauer, J.H. Morrissey, T.W. Meade, D.J. Howarth, S. Barzegar, J.P. Mitchell, R.D. Rosenberg Comparison of novel hemostatic factors and conventional risk factors for prevention of coronary heart disease Circulation 102 2000 2816 2822
14. A.R. Folsom, N. Aleksis, E. Park, V. Salomaa, H. Juneja, K.K. Wu Prospective study of fibrinolytic factors and incident coronary heart disease The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol 21 2001 611 617
15. G.D.O. Lowe, A. Rumley, P.M. Sweetnam, J.W.G. Yarnell, J. Rumley Fibrin D-dimer, markers of activation and the risk of major ischaemic heart disease in the Caerphilly Study Thromb Haemost 85 2001 822 827
16. P.M. Ridker, C.H. Hennekens, A. Cerkus, M.H. Stampher Plasma concentration of cross-linked fibrin degradation products (D-dimer) and the risk of future myocardial infarction among apparently healthy men Circulation 90 1994 2236 2240
17. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, A. Rumley, G.D.O. Lowe Fibrin D-dimer and coronary heart disease; prospective study and meta-analysis Circulation 103 2001 2323 2327
18. M.C. Tataru, J. Heinlich, R. Junker, H. Schulte, A. von Eckardstein, G. Assmann, E. Koehler D-dimer in relation to the severity of atherosclerosis in patients with stable angina pectoris after myocardial infarction Eur Heart J 20 1999 1493 1502
19. E. Réganon, V. Vila, V. Martínez-Sales, A. Vaya, J. Anzar Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction Haematologica 87 2002 740 745
20. M. Saigo, S. Abe, M. Ogawa, I. Maruyama, C. Tei Suppression of fibrinolytic activity and obesity in young patients with myocardial infarction Thromb Haemost 88 2002 878 879